Page 149 - 2021_02-Haematologica-web

Alternative polarization induces tissue factor
35.Ahamed J, Niessen F, Kurokawa T, et al. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood. 2007;109 (12):5251-5259.
36. Scheibenbogen C, Moser H, Krause S, Andreesen R. Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage matura- tion. Haemostasis. 1992;22(4):173-178.
37.Moll T, Czyz M, Holzmuller H, et al. Regulation of the tissue factor promoter in endothelial cells. Binding of NFκB-, AP-1-, and Sp1-like transcription factors. J Biol Chem. 1995;270(8):3849-3857.
38. Kurakula K, Koenis DS, Herzik MA Jr, et al. Structural and cellular mechanisms of pep- tidyl-prolyl isomerase Pin1-mediated enhancement of tissue factor gene expres- sion, protein half-life, and pro-coagulant activity. Haematologica. 2018;103(6):1073- 1082.
39. Iqbal MB, Johns M, Cao J, et al. PARP-14 combines with tristetraprolin in the selec- tive posttranscriptional control of macrophage tissue factor expression. Blood. 2014;124(24):3646-3655.
40. Mehrotra P, Riley JP, Patel R, Li F, Voss L, Goenka S. PARP-14 functions as a transcrip- tional switch for Stat6-dependent gene acti- vation. J Biol Chem. 2011;286(3):1767-1776.
41. Goenka S, Kaplan MH. Transcriptional reg- ulation by STAT6. Immunol Res. 2011;50(1):87-96.
42. Egorina EM, Sovershaev MA, Bjorkoy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to inter-
subject variability. Arterioscler Thromb
Vasc Biol. 2005;25(7):1493-1498.
43. Franco RF, de Jonge E, Dekkers PE, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotox- emia: relationship with activation of coagu-
lation. Blood. 2000;96(2):554-559.
44. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9(6):2752-
2755.
45. Miserez R, Jungi TW. LPS-induced, but not
interferon-gamma-induced procoagulant activity of suspended human macrophages is followed by a refractory state of low pro- coagulant expression. Thromb Res. 1992;65(6):733-744.
46. Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood. 1994;83(1):152-160.
47. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome inte- grates intrinsic and environmental signals. Nat Genet. 2003;33 Suppl:245-254.
48. Wolf P. Nature and significance of platelet products in human plasma. Br J Haematol. 1967;13(3):269-288.
49. Key NS. Analysis of tissue factor positive microparticles. Thromb Res. 2010;125 Suppl 1:S42-S45.
50. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res. 2012;110(2):356-369.
51. Suades R, Padro T, Badimon L. The role of blood-borne microparticles in inflammation
and hemostasis. Semin Thromb Hemost.
2015;41(6):590-606.
52. Bach RR, Moldow CF. Mechanism of tissue
factor activation on HL-60 cells. Blood.
1997;89(9):3270-3276.
53. Zelaya H, Rothmeier AS, Ruf W. Tissue fac-
tor at the crossroad of coagulation and cell signaling. J Thromb Haemost. 2018;16(10): 1941-1952.
54. Baier PK, Wolff-Vorbeck G, Eggstein S, Baumgartner U, Hopt UT. Cytokine expres- sion in colon carcinoma. Anticancer Res. 2005;25(3B):2135-2139.
55. Eriksson O, Asplund A, Hegde G, et al. A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression. Thromb Haemost. 2016;116(6):1050-1059.
56. Wang HW, Joyce JA. Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle. 2010;9(24):4824-4835.
57. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the athero- sclerotic plaque. Proc Natl Acad Sci U S A. 1989;86(8):2839-2843.
58. Stoger JL, Gijbels MJ, van der Velden S, et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012;225(2):461-468.
59. Semeraro F, Ammollo CT, Semeraro N, Colucci M. Tissue factor-expressing mono- cytes inhibit fibrinolysis through a TAFI- mediated mechanism, and make clots resistant to heparins. Haematologica. 2009;94(6):819-826.
haematologica | 2021; 106(2)
463